U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

Results: 61 to 77 of 77

Tests names and labsConditionsGenes, analytes, and microbesMethods

Paraganglioma-Pheochromocytoma Comprehensive Panel

Fulgent Genetics
United States
2911
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Sarcoma Comprehensive Panel

Fulgent Genetics
United States
7026
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Full Comprehensive Cancer Panel

Fulgent Genetics
United States
329127
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Epilepsy Comprehensive NGS Panel

Fulgent Genetics
United States
729398
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Hereditary Cancer Panel

Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia
United States
128130
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Paraganglioma/Pheochromocytoma Panel

Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia
United States
912
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Sarcoma Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
2726
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Hereditary Paraganglioma-Pheochromocytoma Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
1010
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Gastric Cancer Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
2818
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Pheochromocytoma and Paraganglioma Panel

CeGaT GmbH
Germany
713
  • C Sequence analysis of the entire coding region

Cancer Predisposition

Asper Biogene Asper Biogene LLC
Estonia
13598
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

SDHA Single Gene

Fulgent Genetics
United States
41
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Dilated Cardiomyopathy NGS Panel

Fulgent Genetics
United States
18278
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Clinical Exome

Fulgent Genetics
United States
51284672
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Nuclear-Mito NGS Panel

Fulgent Genetics
United States
1103676
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Leukoencephalopathy NGS Panel

Fulgent Genetics
United States
15569
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Cardiovascular NGS Panel

Fulgent Genetics
United States
671250
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 61 to 77 of 77

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.